Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARalpha.
Bougarne
Nadia
N
Paumelle
Réjane
R
Haegeman
Guy
G
Staels
Bart
B
De Bosscher
Karolien
K
D011345:Fenofibrate / Q000627:therapeutic use*; D015870:Gene Expression; D005938:Glucocorticoids / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy; D047493:PPAR alpha / Q000819:agonists*
D005938:Glucocorticoids; D000960:Hypolipidemic Agents; D047493:PPAR alpha; D011345:Fenofibrate